Lindbrook Capital, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$22,126
+45.2%
247
+38.0%
0.00%0.0%
Q2 2023$15,240
+2.9%
1790.0%0.00%0.0%
Q1 2023$14,812
+41.6%
179
+34.6%
0.00%
+100.0%
Q4 2022$10,460
+248.7%
133
+195.6%
0.00%0.0%
Q3 2022$3,000
+200.0%
45
+125.0%
0.00%
Q2 2022$1,0000.0%20
+33.3%
0.00%
Q1 2022$1,000
-66.7%
15
-65.9%
0.00%
-100.0%
Q3 2021$3,000
+200.0%
44
+300.0%
0.00%
Q1 2021$1,0000.0%11
+83.3%
0.00%
Q2 2020$1,0000.0%60.0%0.00%
Q1 2020$1,00060.00%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders